N-acetyl-L-cysteine Ameliorates the Inflammatory Disease Process in Experimental Autoimmune Encephalomyelitis in Lewis Rats

Overview

Journal J Autoimmune Dis

Publisher Biomed Central

Date 2005 May 5

PMID 15869713

Citations 26

Authors

Romesh Stanislaus

Anne G Gilg

Avtar K Singh

Inderjit Singh

Affiliations

Soon will be listed here.

Abstract

We report that N-acetyl-L-cysteine (NAC) treatment blocked induction of TNF-alpha, IL-1beta, IFN-gamma and iNOS in the CNS and attenuated clinical disease in the myelin basic protein induced model of experimental allergic encephalomyelitis (EAE) in Lewis rats. Infiltration of mononuclear cells into the CNS and induction of inflammatory cytokines and iNOS in multiple sclerosis (MS) and EAE have been implicated in subsequent disease progression and pathogenesis. To understand the mechanism of efficacy of NAC against EAE, we examined its effect on the production of cytokines and the infiltration of inflammatory cells into the CNS. NAC treatment attenuated the transmigration of mononuclear cells thereby lessening the neuroinflammatory disease. Splenocytes from NAC-treated EAE animals showed reduced IFN-gamma production, a Th1 cytokine and increased IL-10 production, an anti-inflammatory cytokine. Further, splenocytes from NAC-treated EAE animals also showed decreased nitrite production when stimulated in vitro by LPS. These observations indicate that NAC treatment may be of therapeutic value in MS against the inflammatory disease process associated with the infiltration of activated mononuclear cells into the CNS.

Citing Articles

N-acetylcysteine Clinical Applications.

Yahia Z, Yahia A, Abdelaziz T Cureus. 2024; 16(10):e72252.

PMID: 39450216 PMC: 11499967. DOI: 10.7759/cureus.72252.

Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.

Khalatbari Mohseni G, Hosseini S, Majdinasab N, Cheraghian B Neuropsychopharmacol Rep. 2023; 43(3):382-390.

PMID: 37386885 PMC: 10496087. DOI: 10.1002/npr2.12360.

N-Acetylcysteine Suppresses Microglial Inflammation and Induces Mortality Dose-Dependently via Tumor Necrosis Factor-α Signaling.

Sakai M, Yu Z, Taniguchi M, Picotin R, Oyama N, Stellwagen D Int J Mol Sci. 2023; 24(4).

PMID: 36835209 PMC: 9968039. DOI: 10.3390/ijms24043798.

Dietary supplements in neurological diseases and brain aging.

Naureen Z, Dhuli K, Medori M, Caruso P, Manganotti P, Chiurazzi P J Prev Med Hyg. 2022; 63(2 Suppl 3):E174-E188.

PMID: 36479494 PMC: 9710403. DOI: 10.15167/2421-4248/jpmh2022.63.2S3.2759.

N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis.

Shahrampour S, Heholt J, Wang A, Vedaei F, Mohamed F, Alizadeh M Heliyon. 2021; 7(7):e07615.

PMID: 34377857 PMC: 8327674. DOI: 10.1016/j.heliyon.2021.e07615.

References

Floyd R . Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med. 1999; 222(3):236-45. DOI: 10.1046/j.1525-1373.1999.d01-140.x. View

Benveniste E . Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med (Berl). 1997; 75(3):165-73. DOI: 10.1007/s001090050101. View

Smith K, Kapoor R, Felts P . Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 1999; 9(1):69-92. PMC: 7161906. DOI: 10.1111/j.1750-3639.1999.tb00212.x. View

Stanislaus R, Singh A, Singh I . Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J Neurosci Res. 2001; 66(2):155-62. DOI: 10.1002/jnr.1207. View

Chen M, Gran B, Costello K, Johnson K, Martin R, Dhib-Jalbut S . Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS. Mult Scler. 2001; 7(4):209-19. DOI: 10.1177/135245850100700401. View

Youssef S, Stuve O, Patarroyo J, Ruiz P, Radosevich J, Hur E . The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002; 420(6911):78-84. DOI: 10.1038/nature01158. View

Arnason B, Dayal A, Qu Z, Jensen M, Genc K, Reder A . Mechanisms of action of interferon-beta in multiple sclerosis. Springer Semin Immunopathol. 1996; 18(1):125-48. DOI: 10.1007/BF00792613. View

Bar-Or A, Oliveira E, Anderson D, Hafler D . Molecular pathogenesis of multiple sclerosis. J Neuroimmunol. 2000; 100(1-2):252-9. DOI: 10.1016/s0165-5728(99)00193-9. View

Won J, Im Y, Key L, Singh I, Singh A . The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J Neurosci. 2003; 23(20):7470-8. PMC: 6740773. View

10.

Hussain S, Slikker Jr W, Ali S . Role of metallothionein and other antioxidants in scavenging superoxide radicals and their possible role in neuroprotection. Neurochem Int. 1996; 29(2):145-52. DOI: 10.1016/0197-0186(95)00114-x. View

11.

Bogdan C, Paik J, Vodovotz Y, Nathan C . Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem. 1992; 267(32):23301-8. View

12.

Pozza M, Bettelli C, Aloe L, Giardino L, Calza L . Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution. Brain Res. 2000; 855(1):39-46. DOI: 10.1016/s0006-8993(99)02133-2. View

13.

Pahan K, Sheikh F, Namboodiri A, Singh I . N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med. 1998; 24(1):39-48. DOI: 10.1016/s0891-5849(97)00137-8. View

14.

Stanislaus R, Gilg A, Singh A, Singh I . Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin. Neurosci Lett. 2002; 333(3):167-70. DOI: 10.1016/s0304-3940(02)00943-6. View

15.

. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology. 1993; 43(4):655-61. DOI: 10.1212/wnl.43.4.655. View

16.

Brosnan C, Lee S, Liu J . Regulation of inducible nitric oxide synthase expression in human glia: implications for inflammatory central nervous system diseases. Biochem Soc Trans. 1997; 25(2):679-83. DOI: 10.1042/bst0250679. View

17.

ADAMS C, Poston R, Buk S . Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci. 1989; 92(2-3):291-306. DOI: 10.1016/0022-510x(89)90144-5. View

18.

Pahan K, Namboodiri A, Sheikh F, Smith B, Singh I . Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem. 1997; 272(12):7786-91. DOI: 10.1074/jbc.272.12.7786. View

19.

Perry T, Yong V, Clavier R, Jones K, Wright J, Foulks J . Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci Lett. 1985; 60(2):109-14. DOI: 10.1016/0304-3940(85)90229-0. View

20.

Koedel U, Pfister H . Protective effect of the antioxidant N-acetyl-L-cysteine in pneumococcal meningitis in the rat. Neurosci Lett. 1997; 225(1):33-6. DOI: 10.1016/s0304-3940(97)00177-8. View